Monitoring prostate cancer using blood tests and imaging techniques
Integrated radiomic and liquid biopsy monitoring in SWOG S1802: A phase 3 therapeutic trial for metastatic prostate cancer
This study is looking at new ways to keep an eye on advanced prostate cancer by using blood tests and special imaging techniques, which could help doctors tailor treatments just for you without needing more invasive procedures.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11015787 on NIH RePORTER |
What this research studies
This research investigates how to monitor metastatic prostate cancer through two innovative methods: liquid biopsy and radiomic analysis. Liquid biopsy involves analyzing blood samples to detect cancer-related cells and genetic material, while radiomic analysis extracts detailed imaging features from scans. By combining these approaches, the research aims to provide a noninvasive way to track disease progression and response to therapy over time. This could lead to better personalized treatment strategies for patients with advanced prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with metastatic prostate cancer who are undergoing treatment.
Not a fit: Patients with localized prostate cancer or those not receiving treatment for metastatic disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and treatment strategies for men with metastatic prostate cancer.
How similar studies have performed: Previous research has shown promise in using liquid biopsies and radiomic analysis separately, but this integrated approach is relatively novel.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Goldkorn, Amir — University of Southern California
- Study coordinator: Goldkorn, Amir
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.